RxDoctor Payments Data

Teresa Gentile, MD

Hematology & Oncology · Syracuse, NYNPI 1902834245

Payments from drug & device makers

What this record shows

This record is dominated by education: $29 of the $29 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, E.r. Squibb & Sons, L.L.C.. That places this record below the midpoint for hematology & oncology clinicians in NY, where the typical reported total is $1,337.

$29in general payments, 2019–2025

Across 2 payments — averaging $14.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$29
$595,965in research payments, 2019–2025

Across 57 payments — averaging $10,456 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$165K
  • Otsuka Pharmaceutical Co., Ltd.$159K
  • Janssen Research & Development, LLC$92K
  • Syndax Pharmaceuticals, Inc.$76K
  • Morphosys AG$37K
  • Astellas Pharma Global Development$29K
  • plus $37K from 4 others

What the payments were for

  • Education$29100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
E.r. Squibb & Sons, L.L.C.2$29

How this compares

$29 in reported general payments places this provider in the 5th percentile of 967 hematology & oncology providers in New York.

See all hematology & oncology providers in New York →

Medicare billing

Part B allowed, 2024
$55,845
Medicare patients
123
Services billed
539

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Syracuse

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →